Astellas Pharma Articles
Taisho denies purchase speculation
20 February 2006
Astellas Pharma's Vaprisol gains FDA approval
9 January 2006
Apoxis acquires rights for anticancer drug FK866
19 December 2005
Theravance and Astellas finalize telavancin deal
12 December 2005
CV Thera/Astellas's regadenoson meets Ph III endpoint
22 August 2005
Astellas launches oral Harnal
20 June 2005
Japan stock market week to May 30
6 June 2005
Astellas: merger costs cause 75% profit drop
30 May 2005
SciClone Pharma names Ira Lawrence as CEO
9 May 2005
Astellas' Prograf approved for rheumatoid arthritis
18 April 2005
UPDATE: Yamanouchi drops Phytopharm's Cogane
7 March 2005
Sankyo and Daiichi prepare to merge?
28 February 2005
Canada's Cardiome a takeover target for Japan's Astellas Pharma?
28 February 2005
Fujisawa's 9-month sales rise 2.5%
21 February 2005
Tokyo pharma stocks - week to November 15
22 November 2004
Aspirations of Astellas Pharma, the merged Yamanouchi/Fujisawa
22 November 2004
Zepharma's business structure unveiled
11 October 2004
Tokyo pharma stocks - week to September 20
27 September 2004
Tokyo pharma stocks - week to May 31
7 June 2004
Yamanouchi and Fujisawa complete merger details
31 May 2004
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Elan puts up formal "for sale" notice
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
